Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

James Morrow, MD, PhD

  • Physician
  • Instructor in Pediatrics, Harvard Medical School

Appointment Phone

  • 617-632-3270 (established patients)
  • 888-733-4662 (new patients)

Fax

  • 617-632-4410

General

Treatment Centers

Discipline

Clinical Interests

Developmental therapeutics

Location

Background

Fellowship

  • Dana-Farber Cancer Institute

Residency

  • Boston Combined Residency Program in Pediatrics

Medical School

  • Case Western Reserve University

Biography

Dr. Morrow received his bachelor’s degree in biology with highest honors at Pennsylvania State University. He attended medical school at Case Western Reserve University, where he was selected as an HHMI-NIH Research Scholar. During this fellowship James worked in the pediatric oncology branch at the National Cancer Institute (NCI), studying the molecular mechanisms of solid tumor metastasis. James went on to complete a PhD, splitting research time between Case Western and NCI. His research showed that gene enhancer dysregulation is a key driver of osteosarcoma metastasis. James completed his pediatric residency in the Boston Combined Residency Program at Boston Children’s Hospital. He then completed his Pediatric Hematology/Oncology Fellowship at Dana-Farber Cancer Institute. James is currently an attending physician treating children and adolescents with cancer and hematologic diseases. He is also completing research in the lab of Bradley Bernstein at DFCI, studying the developmental origins and evolution of pediatric solid tumors.